CI in the 13F filings
The Cigna Group · CUSIP 125523100
- Quarter end
- 31 Dec 2023
- the date the book describes
- Filed
- 5 Nov 2026
- latest of these filings; the earliest 8 Feb 2024
- Managers listing it
- 31
- at least, of 95 tracked, among listed positions
- Comparable managers
- 93
- filed both Q3 2023 and Q4 2023; 22 listed it in both
- Shares listed
- 68,846,455
- combined, among listed positions
- Reported value
- $20.6bn
- combined, at the quarter end
Among the 93 comparable managers: 16 buyers (opened or added shares) and 19 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing CI in Q4 2023
31 of 31 holders
Largest increases and reductions, by shares
Increases
- Glenview Capital Management LLCexisting position · 2,142,526 shares now+593,707
- Voloridge Investment Management LLCnew position · 574,575 shares now+574,575
- Man Group PLCexisting position · 682,464 shares now+431,289
- AllianceBernstein LPexisting position · 1,013,800 shares now+391,356
- Renaissance Technologies LLCnew position · 247,059 shares now+247,059
Reductions
- Capital World Investorsexisting position · 1,180,433 shares now-1,570,723
- Fidelity (FMR LLC)existing position · 14,521,171 shares now-1,446,192
- Marshall Wace LLPexisting position · 70,021 shares now-818,141
- MFS Investment Managementexisting position · 11,364,122 shares now-469,631
- Invesco Ltdexisting position · 2,108,317 shares now-392,494
New positions and exits
New (3)
Exited (4)
- Capital Research Global Investorswas $114m
- Farallon Capital Management LLCwas $105m
- Element Capital Management LLCwas $7.5m
- Maverick Capital Ltdwas $470k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q4 2018 | 33 | $20.6bn | n.a. | n.a. |
| Q1 2019 | 27 | $18.1bn | n.a. | n.a. |
| Q2 2019 | 26 | $17.5bn | n.a. | n.a. |
| Q3 2019 | 27 | $16.6bn | n.a. | n.a. |
| Q4 2019 | 28 | $23.1bn | n.a. | n.a. |
| Q1 2020 | 26 | $19.8bn | n.a. | n.a. |
| Q2 2020 | 29 | $20.8bn | n.a. | n.a. |
| Q3 2020 | 34 | $18.1bn | n.a. | n.a. |
| Q4 2020 | 22 | $21.9bn | n.a. | n.a. |
| Q1 2021 | 24 | $23.9bn | n.a. | n.a. |
| Q2 2021 | 31 | $22.5bn | n.a. | n.a. |
| Q3 2021 | 30 | $17.8bn | n.a. | n.a. |
| Q4 2021 | 26 | $20.1bn | n.a. | n.a. |
| Q1 2022 | 28 | $20.4bn | n.a. | n.a. |
| Q2 2022 | 32 | $22.1bn | n.a. | n.a. |
| Q3 2022 | 31 | $21.5bn | n.a. | n.a. |
| Q4 2022 | 30 | $24.7bn | n.a. | n.a. |
| Q1 2023 | 35 | $18.2bn | n.a. | n.a. |
| Q2 2023 | 30 | $19.8bn | n.a. | n.a. |
| Q3 2023 | 28 | $19.8bn | n.a. | n.a. |
| Q4 2023 | 31 | $20.6bn | 16 | 19 |
| Q1 2024 | 28 | $24.0bn | 14 | 17 |
| Q2 2024 | 28 | $19.5bn | 15 | 15 |
| Q3 2024 | 25 | $20.2bn | 13 | 14 |
| Q4 2024 | 23 | $15.2bn | 13 | 12 |
| Q1 2025 | 24 | $18.4bn | 15 | 10 |
| Q2 2025 | 34 | $19.5bn | 24 | 10 |
| Q3 2025 | 28 | $16.2bn | 14 | 15 |
| Q4 2025 | 21 | $14.6bn | 20 | 23 |
| Q1 2026 | 26 | $13.5bn | 19 | 20 |
| Q2 2026 | 28 | $13.0bn | 22 | 19 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
CI and UNH →CI and ELV →CI and HUM →Choose a stock to compare with CI →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own CI, latest filings →Back to the 13F Explorer →